Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:1218-1224
Published online before print November 6, 2003, doi: 10.1161/01.RES.0000105570.34585.F2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
93/12/1218    most recent
01.RES.0000105570.34585.F2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishida, M.
Right arrow Articles by Yoshizumi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishida, M.
Right arrow Articles by Yoshizumi, M.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell signalling/signal transduction
Right arrow Hypertrophy
Right arrow Other Vascular biology
(Circulation Research. 2003;93:1218.)
© 2003 American Heart Association, Inc.


Molecular Medicine

Mnk1 Is Required for Angiotensin II–Induced Protein Synthesis in Vascular Smooth Muscle Cells

Mari Ishida, Takafumi Ishida, Hidekatsu Nakashima, Narimasa Miho, Kiyoshi Miyagawa, Kazuaki Chayama, Tetsuya Oshima, Masayuki Kambe, Masao Yoshizumi

From the Department of Human Genetics (M.I., K.M.), Research Institute for Radiation Biology and Medicine, Department of Clinical Laboratory Medicine (H.N., T.O., M.K.), Department of Medicine and Molecular Science (T.I., N.M., K.C.), and Department of Cardiovascular Physiology and Medicine (M.Y.), Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.

Correspondence to Takafumi Ishida, MD, PhD, Department of Medicine and Molecular Science, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. E-mail ishidat{at}hiroshima-u.ac.jp

Angiotensin II (Ang II) stimulates protein synthesis in vascular smooth muscle cells (VSMCs), possibly secondary to regulatory changes at the initiation of mRNA translation. Mitogen-activated protein (MAP) kinase signal–integrating kinase-1 (Mnk1), a substrate of ERK and p38 MAP kinase, phosphorylates eukaryotic initiation factor 4E (eIF4E), an important factor in translation. The goal of the present study was to investigate the role of Mnk1 in Ang II–induced protein synthesis and to characterize the molecular mechanisms by which Mnk1 and eIF4E is activated in rat VSMCs. Ang II treatment resulted in increased Mnk1 activity and eIF4E phosphorylation. Expression of a dominant-negative Mnk1 mutant abolished Ang II–induced eIF4E phosphorylation. PD98059 or introduction of kinase-inactive MEK1/MKK1, but not SB202190 or kinase-inactive p38 MAP kinase, inhibited Ang II–induced Mnk1 activation and eIF4E phosphorylation, suggesting that ERK, but not p38 MAP kinase, is required for Ang II–induced Mnk1-eIF4E activation. Further, dominant-negative constructs for Ras, but not for Rho, Rac, or Cdc42, abolished Ang II–induced Mnk1 activation. Finally, treatment of VSMCs with CGP57380, a novel specific kinase inhibitor of Mnk1, resulted in dose-dependent decreases in Ang II–stimulated phosphorylation of eIF4E, protein synthesis, and VSMC hypertrophy. In summary, these data demonstrated that (1) Ang II–induced Mnk1 activation is mediated by the Ras-ERK cascade in VSMCs, and (2) Mnk1 is involved in Ang II–mediated protein synthesis and hypertrophy, presumably through the activation of translation-initiation. The Mnk1-eIF4E pathway may provide new insights into molecular mechanisms involved in vascular hypertrophy and other Ang II–mediated pathological states.


Key Words: angiotensin II • protein synthesis • Mnk1 • vascular smooth muscle cells




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. M. DeWire, J. Kim, E. J. Whalen, S. Ahn, M. Chen, and R. J. Lefkowitz
{beta}-Arrestin-mediated Signaling Regulates Protein Synthesis
J. Biol. Chem., April 18, 2008; 283(16): 10611 - 10620.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. M. Rowlett, C. A. Chrestensen, M. Nyce, M. G. Harp, J. W. Pelo, F. Cominelli, P. B. Ernst, T. T. Pizarro, T. W. Sturgill, and M. T. Worthington
MNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G452 - G459.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi
Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells
Hypertension, October 1, 2006; 48(4): 534 - 540.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Miho, T. Ishida, N. Kuwaba, M. Ishida, K. Shimote-Abe, K. Tabuchi, T. Oshima, M. Yoshizumi, and K. Chayama
Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells
Cardiovasc Res, November 1, 2005; 68(2): 289 - 298.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. G Proud
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy
Cardiovasc Res, August 15, 2004; 63(3): 403 - 413.
[Abstract] [Full Text] [PDF]